Cav 2.2 blocker 2

• UNSPSC Description:

  Cav 2.2 blocker 2 is a Cav2.2 calcium channel blocker extracted from patent WO2017046581A1, compound 1. Cav 2.2 blocker 2 can reverses hyperalgesia associated with an injury or inflammation in conjunction with the opioid[1].

• Target Antigen:

  Calcium Channel

• Type:

  Reference compound

• Related Pathways:

  Membrane Transporter/Ion Channel;Neuronal Signaling

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/cav-2-2-blocker-2.html

• Purity:

  98.45

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  O=C(C1=CC=CN=C1C)N2[C@@H](C)CN(S(=O)(C3=CC=C(C(F)(F)F)C=C3)=O)CC2

• Molecular Weight:

  427.44

• References & Citations:

  [1]Ali Z, et, al. Composition comprising cav2.2 calcium channel blocker and opioid. WO2017046581A1.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  Phase 2

• CAS Number:

  1204535-44-3